Santarus (SNTS)
Santarus Revenues: 45.88M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
SNTS Revenues Rankings
| Overall | 34th percentile | 2918 of 4431 |
| Sector | 57th percentile | 199 of 471 in Healthcare |
| Industry | 78th percentile | 28 of 132 in Biotechnology |
SNTS Revenues Range, Past 5 Years
| Minimum | 18.07M | Sep 2010 |
| Maximum | 62.38M | Dec 2009 |
| Average | 33.41M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these SNTS related companies
SNTS News
$SNTS Mentioned more than normal on StockTwits - Currently at 7 x average daily social activity
about 3 days ago by TradeIdeasQuant
about 3 days ago by TradeIdeasQuant
$SNTS - Still long @ $4.75. Moved Trailing Stop @ $4.76 from 3 prior Stops - http://stks.co/41NS
about 3 days ago by TraderFoxxx
about 3 days ago by TraderFoxxx
8 breakouts: $AUTH, $RAI, $SNTS (gap). One sub-$1 and one $1-2. The number of breakouts slowly rising, but still a long way to go.
about 3 days ago by fallondpicks
about 3 days ago by fallondpicks
Canadian Imperial Bank of Commerce, Spreadtrum Communications Among Stocks Up on High Volume Tuesday
May 29, 12:33PM Fox Business
May 29, 12:33PM Fox Business
Santarus Announces Presentation of UCERIS Phase III Extended Use Data at Digestive Disease Week Meeting
May 18, 4:00AM Business Wire
May 18, 4:00AM Business Wire
Santarus' CEO Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript)
May 15, 8:19PM Seeking Alpha
May 15, 8:19PM Seeking Alpha
$SNTS - Still long @ $4.75. Current Trailing Stop @ $4.75 - http://stks.co/3m1j
about 22 days ago by TraderFoxxx
about 22 days ago by TraderFoxxx
$SNTS http://stks.co/3lXw from watch list over first line on volume of 18% full day average
about 22 days ago by StockTiger
about 22 days ago by StockTiger
Listen to $SNTS Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3jHb
about 24 days ago by earningscast
about 24 days ago by earningscast
Santarus to Present at Bank of America Merrill Lynch 2012 Health Care Conference
May 07, 4:00AM Business Wire
May 07, 4:00AM Business Wire
$SNTS nice move today!! they run drugs for my new postion $DEPO . hope she follows suit!
about 32 days ago by HighGrowthFinancial
about 32 days ago by HighGrowthFinancial
$SNTS filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3X57
about 36 days ago by MarketBrief
about 36 days ago by MarketBrief
Santarus to Hold First Quarter 2012 Financial Results Conference Call on May 8
Apr 26, 4:00AM Business Wire
Apr 26, 4:00AM Business Wire
$SNTS - Moved Trailing Stop higher to $4.75 from two prior Stops of $4.20 & $3.65 http://stks.co/3Vwh
about 37 days ago by TraderFoxxx
about 37 days ago by TraderFoxxx
Santarus Appoints Alessandro E. Della Chà and Matthew W. Strobeck to Board of Directors
Apr 10, 4:00AM Business Wire
Apr 10, 4:00AM Business Wire
Pharming and Hyupjin Corporation announce commercialisation agreement for RUCONEST in Korea
Mar 26, 1:03AM Thomson Reuters ONE
Mar 26, 1:03AM Thomson Reuters ONE
Santarus to Hold Fourth Quarter and Full Year 2011 Financial Results Conference Call on March 5
Feb 27, 4:00AM Business Wire
Feb 27, 4:00AM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SNTS | 6.675 | +0.01 | +0.23% | 407.86M |
| SNTA | 5.11 | +0.30 | +6.24% | 277.20M |
| SNT | 0.245 | +0.01 | +6.52% | 21.13M |
| SGU | 3.93 | -0.02 | -0.51% | 242.14M |
| SGRP | 1.24 | +0.00 | +0.00% | 24.92M |
| SGOL | 160.51 | +5.92 | +3.83% | |
| SGNT | 15.98 | +0.03 | +0.19% | 444.69M |
| SGMS | 8.20 | -0.34 | -3.98% | 790.29M |
| SGMO | 4.23 | -0.21 | -4.73% | 233.37M |
| SGMA | 3.77 | -0.03 | -0.79% | 14.86M |
